ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Politics

Japan to ease regulations on medical AI software

Government to allow updates without regulatory approval, shorten review process

Japan plans to allow companies to update medical artificial intelligence software without regulatory approval by the end of 2022.

TOKYO -- The Japanese government is planning to ease regulations for medical artificial intelligence software to boost the domestic market, Nikkei has learned.

The government is considering cutting the need for regulatory approval to update such software as early as by the end of 2022. This will make it easier for companies to improve software performance and to detect diseases more quickly. The medical software market is dominated by foreign companies, and the deregulation is aimed at helping the domestic market recover.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more